Skip to main content

Table 2 Cox regression models for predictors of developing end stage renal disease in derivation cohort

From: Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus – a population-based retrospective cohort study

Predictors

Male

Female

HRa

95%CI

P-value

HRa

95%CI

P-value

Socio-demographics

 Age, years

1.06

(1.05,1.08)

<0.001*

1.03

(1.02,1.05)

<0.001*

 Smoker (Non-smoker)

1.29

(1.11,1.50)

0.001*

   

Disease characteristics

 Duration of T2DM, years

   

1.01

(1.00,1.02)

0.046*

 STDR (No)

1.47

(1.18,1.84)

0.001*

   

Treatment modalities

 Anti-hypertensive drugs used (No)

1.54

(1.21,1.97)

0.001*

1.66

(1.21,2.26)

0.002*

 Oral drug (No)

1.37

(1.07,1.75)

0.011*

1.98

(1.43,2.75)

<0.001*

 Insulin drug (No)

9.79

(1.66,57.62)

0.012*

1.73

(1.30,2.29)

<0.001*

Clinical parameters

 BMI, kg/m2

   

0.85

(0.77,0.95)

0.002*

 BMI2, kg/m2

   

1.003

(1.001,1.005)

0.001*

 HbA1c, %

0.79

(0.64,0.98)

0.036*

0.70

(0.49,0.99)

0.046*

 HbA1c2, %

1.02

(1.01,1.03)

0.002*

1.03

(1.01,1.05)

0.013*

 SBP, mmHg

1.01

(1.01,1.02)

<0.001*

1.01

(1.00,1.01)

0.025*

 DBP, mmHg

0.93

(0.88,0.98)

0.009*

0.92

(0.86,0.98)

0.007*

 DBP2, mmHg

1.0004

(1.0000,1.0008)

0.039*

1.001

(1.000,1.001)

0.017*

 ln(Urine ACR + 1), mg/mmol

3.15

(2.11,4.69)

<0.001*

1.45

(1.37,1.53)

<0.001*

 eGFR (>90 ml/min/1.73m2)

  60-89 ml/min/1.73m2

2.45

(2.08,2.88)

<0.001*

2.00

(0.38,10.51)

0.412

  < 60 ml/min/1.73m2

8.76

(7.08,10.84)

<0.001*

112.06

(23.97,523.76)

<0.001*

 Age interaction term

 Age*eGFR(>90 ml/min/1.73m2)

  60-89 ml/min/1.73m2

   

1.003

(0.979,1.028)

0.816

  < 60 ml/min/1.73m2

   

0.97

(0.95,0.99)

0.006*

 Age*insulin

0.97

(0.95,1.00)

0.028*

   

 Age* ln(Urine ACR + 1)

0.99

(0.98,0.99)

<0.001*

   
  1. T2DM Type 2 Diabetes Mellitus, STDR Sight Threatening Diabetic Retinopathy, BMI Body Mass Index, HbA1c Hemogloblin A1c, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, TC Total Cholesterol, HDL-C High-density Lipoprotein-Cholesterol, ACR Albumin/Creatinine Ratio, eGFR estimated Glomerular Filtration Rate, T2DM Type 2 Diabetes Mellitus, HR Hazard Ratio
  2. * Significant difference (P < 0.05)
  3. a HR > 1 indicates greater risk of event occurrence